Active Ingredient: ZOLMITRIPTAN
Proprietary Name: ZOLMITRIPTAN
Dosage Form; Route of Administration: SPRAY; NASAL
Strength: 2.5MG/SPRAY
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212469
Product Number: 001
Approval Date: Sep 30, 2021
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information